United Therapeutics
(NASDAQ:UTHR)
$276.33
-3.56[-1.27%]
Last update: 12:59PM (Delayed 15-Minutes)
Get Real Time Here
Day Range275.26 - 280.4352 Wk Range158.38 - 280.27Open / Close279.89 / -Float / Outstanding44.8M / 45.6M
Vol / Avg.88K / 380.6KMkt Cap12.6BP/E19.0550d Avg. Price235.12
Div / Yield-Payout Ratio-Total Float44.8MEPS5.26

United Therapeutics Stock (NASDAQ:UTHR), Quotes and News Summary

United Therapeutics Stock (NASDAQ: UTHR) stock price, news, charts, stock research, profile.

Loading...
Day Range275.26 - 280.4352 Wk Range158.38 - 280.27Open / Close279.89 / -Float / Outstanding44.8M / 45.6M
Vol / Avg.88K / 380.6KMkt Cap12.6BP/E19.0550d Avg. Price235.12
Div / Yield-Payout Ratio-Total Float44.8MEPS5.26
StockNews - Nov 23, 2022, 7:18AM
StockNews - Nov 14, 2022, 7:05AM
StockNews - Oct 26, 2022, 4:43AM
Seeking Alpha - Sep 12, 2022, 12:08PM
Seeking Alpha - Sep 1, 2022, 12:31PM
Sector: Health Care.Industry: Biotechnology
United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. Most of the company's sales are generated within the United States. United Therapeutics also markets a pediatric oncology drug, but its focus largely remains in pulmonary arterial hypertension.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-23
REV
Q3 2022Est.ActualSurprise
EPS3.8904.910 1.0200
REV493.200M516.000M22.800M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy United Therapeutics (UTHR) stock?

A

You can purchase shares of United Therapeutics (NASDAQ: UTHR) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are United Therapeutics's (UTHR) competitors?

Q

What is the target price for United Therapeutics (UTHR) stock?

A

The latest price target for United Therapeutics (NASDAQ: UTHR) was reported by JP Morgan on Thursday, November 3, 2022. The analyst firm set a price target for 265.00 expecting UTHR to fall to within 12 months (a possible -4.10% downside). 14 analyst firms have reported ratings in the last year.

Q

Current Stock Price for United Therapeutics (UTHR)?

A

The stock price for United Therapeutics (NASDAQ: UTHR) is $276.33 last updated Today at December 1, 2022, 5:59 PM UTC.

Q

Does United Therapeutics (UTHR) pay a dividend?

A

There are no upcoming dividends for United Therapeutics.

Q

When is United Therapeutics (NASDAQ:UTHR) reporting earnings?

A

United Therapeutics’s Q4 earnings are confirmed for Thursday, February 23, 2023.

Q

Is United Therapeutics (UTHR) going to split?

A

There is no upcoming split for United Therapeutics.

Q

What sector and industry does United Therapeutics (UTHR) operate in?

A

United Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.